Castle Biosciences (CSTL) Research & Development (2018 - 2026)
Castle Biosciences' Research & Development history spans 8 years, with the latest figure at $13.5 million for Q4 2025.
- On a quarterly basis, Research & Development rose 14.8% to $13.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $51.8 million, a 0.37% change, with the full-year FY2025 number at $51.8 million, changed 0.37% from a year prior.
- Research & Development hit $13.5 million in Q4 2025 for Castle Biosciences, up from $13.0 million in the prior quarter.
- Over the last five years, Research & Development for CSTL hit a ceiling of $14.4 million in Q1 2023 and a floor of $5.9 million in Q1 2021.
- Historically, Research & Development has averaged $11.6 million across 5 years, with a median of $12.5 million in 2024.
- Biggest five-year swings in Research & Development: surged 151.22% in 2021 and later fell 9.54% in 2025.
- Tracing CSTL's Research & Development over 5 years: stood at $9.4 million in 2021, then rose by 19.74% to $11.3 million in 2022, then grew by 14.9% to $13.0 million in 2023, then dropped by 9.4% to $11.8 million in 2024, then rose by 14.8% to $13.5 million in 2025.
- Business Quant data shows Research & Development for CSTL at $13.5 million in Q4 2025, $13.0 million in Q3 2025, and $12.8 million in Q2 2025.